Angel Kay's Toy Drive'
A gun violence toy drive in Jackson
A gun violence toy drive in Jackson
Pope Francis made repeated appeals for peace during his landmark trip to the Democratic Republic of Congo this week, but there was no let-up in fighting in the east.- 'Your tears are my tears' - On Wednesday in Kinshasa, Pope Francis told conflict victims "your tears are my tears".Â
Tesla Inc has cut prices of some of its car models in South Korea, a local Tesla sales official said on Friday, the second straight month the U.S. electric vehicle maker has lowered prices. The Tesla official confirmed the new prices of the models. In January, Tesla cut the prices of some of its cars in South Korea.
An underground water main break in Hollywood sent a fountain gushing 30 to 40 feet into the air and rivers flooding down local streets Thursday night.
Tesla Inc has cut prices of some of its car models in South Korea, a local Tesla sales official said on Friday, the second straight month the U.S. electric vehicle maker has lowered prices. The Tesla official confirmed the new prices of the models. In January, Tesla cut the prices of some of its cars in South Korea.
Train drivers are taking part in a fresh round of strikes on Friday, heaping further misery onto weary rail commuters after an earlier strike in the week.
Japanese startup Aerwins Technologies, which is selling a Star Wars-inspired $555,000 hoverbike, has received approval to list on the NASDAQ in a merger with blank-check firm Pono Capital Corp, the manufacturer said on Friday. Aerwins, which is taking orders for the XTurismo hoverbike with a motorcycle-like body on top of propellers that it unveiled last year, estimates it will be valued at $600 million in the transaction. The deal comes at a time when other mobility startups have faced difficulty raising funding, with valuations under pressure and a sharp reversal of what had been a market boom for listings through special-purpose acquisition companies (SPAC).
A hospice facility in Iowa has been fined $10,000 after it mistakenly presumed a woman dead hours before she was discovered gasping for air inside a body bag at a funeral home, officials said.
Officials decided against shooting it down amid concerns over the danger of falling debris.
Luja Coloplast's new intermittent catheter Lujaâ„¢ addresses important risk factors for urinary tract infections, a significant burden for people using intermittent catheters as well as healthcare systems as a whole. Luja Coloplast's new intermittent catheter Lujaâ„¢ addresses important risk factors for urinary tract infections, a significant burden for people using intermittent catheters as well as healthcare systems as a whole. The new intermittent catheter Lujaâ„¢ addresses important risk factors f
A man left what appeared to be deceased animal remains and a human jawbone at the San Bernardino Police Department on Thursday, and now officers are seeking for public assistance in identifying him.
Q1 2022/23 Interim financial results, Q1 2022/23 1 October 2022 – 31 December 2022 Coloplast delivered a solid start to the year with 7% organic growth and a 29% EBIT margin before special items Coloplast delivered 7% organic growth in Q1. Reported revenue in DKK was up by 18%. Organic growth rates by business area: Ostomy Care 8%, Continence Care 7%, Wound and Skin Care 1% (Wound Care -4%), and Interventional Urology 11%.Solid start in Chronic Care, with strong momentum in Ostomy Care across re
LOS ANGELES, February 03, 2023--The world's largest awards organization, the Huading Awards Group, recently announced at its Hollywood headquarters in the U.S. that it was going to officially upgrade its brand in 2023 to create world-class entertainment awards comparable to the Oscar and Grammy.
The simplest way to benefit from a rising market is to buy an index fund. Active investors aim to buy stocks that...
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company. Close of business 02 Feb 2023. Estimated NAV Euro Shares Sterling Shares Estimated NAV € 27.1596 £ 23.9157 Estimated MTD return -0.45 % -0.46 % Estimated YTD return -2.20 % -2.09 % Estimated ITD return 171.60 % 139.16 % NAV and returns are calculated net of management and performance fees Market information Euro Shares Amsterda
Qurient Co. Ltd. ("Qurient", KRX: 115180), a clinical-stage biotechnology company based in South Korea, and TB Alliance, a not-for-profit organization dedicated to the discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs, announced today that they have entered into a license agreement to develop and commercialize telacebec (Q203), a first-in-class orally available cytochrome bc1 inhibitor for the treatment of tuberculosis (TB) and other non-tuberculosis
SAMPO PLC STOCK EXCHANGE RELEASE 03/02/2023 at 08:30 am Sampo plc’s share buybacks 02/02/2023 On 02/02/2023 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows: Sampo plc’s share buybacksAggregated daily volume (in number of shares)Daily weighted average price of the purchased shares*Market (MIC Code) 11,48748.64AQEU 16,17248.62CEUX 10,83048.63TQEX 81,06448.62XHELTOTAL119,55348.62 *rounded to two decimals On 9 June 2022,
Strong sales performance and double digit EPS growth marking the achievement of the 2022 profitability milestone Paris, February 3, 2023 Q4 2022 sales growth of 2.6% at CER and business EPS(1) growth of 17.4% at CER Specialty Care grew 18.1% driven by Dupixent® (€2,402 million, +42.1%) and new product launchesVaccines sales (-16.3%) reflecting influenza and PPH sales phasing (Q3 influenza sales: up 32.4%) as well as ramp up of non-consolidated Vaxelis® salesGeneral Medicines core assets up 8.0%
LYON, France, February 03, 2023--Regulatory News: MaaT Pharma (EURONEXT: MAAT – the "Company"), a French clinical-stage biotech and a pioneer in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival outcomes for patients with cancer, today reported that the U.S. Food and Drug Administration (FDA or the "Agency") has responded to the Company’s Investigational New Drug (IND) Application to initiate in the U.S. an open-label, single arm Phase 3 pivotal clinical t
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company. Close of business 02 Feb 2023. Estimated NAV Euro Shares Sterling Shares Estimated NAV € 27.1596 £ 23.9157 Estimated MTD return -0.45 % -0.46 % Estimated YTD return -2.20 % -2.09 % Estimated ITD return 171.60 % 139.16 % NAV and returns are calculated net of management and performance fees Market information Euro Shares Amsterda